Skip to main content

Sheng Luo CV

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road, Suite 1102, 11082 Hock Plaza, Durham, NC 27705
CV

Current Duke Appointments & Affiliations


Professor of Biostatistics & Bioinformatics · 2021 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics
Member of the Duke Cancer Institute · 2026 - Present Duke Cancer Institute, Institutes and Centers

Recent News Items


Published November 27, 2018
The DCRI’s Sheng Luo on the benefit of biostatistics
Published January 8, 2018
Researchers develop new model to predict progression to Alzheimer’s in patients with mild cognitive impairment
Published May 7, 2017
IOS Press
Prediction of Conversion to Alzheimer’s Disease with Longitudinal Measures and Time-To-Event Data

View All News Items

Recent Scholarly Works


Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III cannot Be Reliably Reduced for Predicting Time to Initiation of Parkinsonian Medication in Early Parkinson's Disease: An Item-Level Sensitivity Analysis.

Journal article Mov Disord Clin Pract · October 2, 2026 BACKGROUND: The sum of clinician-rated MDS-UPDRS Part III Motor Examination items is widely used in Parkinson's disease (PD), but item- or subset prognostic value remains unclear. Whereas reduced subsets of patient-reported Parts IB + II show improved util ... Full text Link to item Cite

Clinical Practice Outcomes With Lecanemab for Alzheimer Disease.

Journal article Neurol Open Access · September 2026 BACKGROUND AND OBJECTIVES: Lecanemab, an antiamyloid monoclonal antibody, received US Food and Drug Administration approval in July 2023 to treat amyloid-positive early stages of Alzheimer disease (AD) and has since been adopted in many countries. The prim ... Full text Link to item Cite

Erythrocyte Count, Anemia, and the Human Natural Lifespan Limit: Evidence from the Long Life Family Study.

Journal article bioRxiv · June 26, 2026 Erythropoiesis is the most replication-intensive process in the body. Its lifelong replicative demands may erode hematopoietic cells' replicative capacity, leading to a decline in erythrocyte count (EC) in older adults and limiting their lifespan. We exami ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Duke Artificial Intelligence and Technology Collaboratory for Aging: Governance and Evaluation (Duke AITC-AIGE)

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2026 - 2031

Post-Recurrence Survival in Patients with Recurrent Breast Cancer: Identifying Key Predictors and Standardizing Assessments

ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2031

AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound

ResearchBiostatistician · Awarded by National Institutes of Health · 2025 - 2029

View All Grants

Education


Johns Hopkins University · 2008 Ph.D.

External Links


Homepage CV